INOGEN, INC. (INGN) Quick Ratio
- Quick ratio · latest quarter: Value 2.14×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 2.14× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $151.70M ÷ $70.86M ≈ 2.14× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 151.70M USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 70.86M USD | Liabilities, Current |
| Cash and equivalents | 87.28M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 18.26M USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 46.16M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 28.63M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $151.70M | $70.86M | $87.28M | $18.26M | $46.16M | $28.63M | 2.14× |
| 2026-03-31 | $152.04M | $61.45M | $93.11M | $17.06M | $41.87M | $24.99M | 2.47× |
| 2025-12-31 | $158.44M | $63.53M | $103.73M | $15.85M | $38.86M | $25.97M | 2.49× |
| 2025-09-30 | $163.60M | $64.94M | $106.48M | $16.75M | $40.37M | $25.07M | 2.52× |
| 2025-06-30 | $161.02M | $67.07M | $103.69M | $18.75M | $38.59M | $24.31M | 2.40× |
| 2025-03-31 | (m) | $65.45M | $118.89M | (m) | $36.62M | $26.27M | (m) |
| 2024-12-31 | (m) | $76.69M | $113.80M | (m) | $29.56M | $24.81M | (m) |
| 2024-09-30 | $154.90M | $72.40M | $105.69M | $14.97M | $34.23M | $23.32M | 2.14× |
| 2024-06-30 | $153.72M | $72.19M | $97.92M | $19.77M | $36.04M | $24.05M | 2.13× |
| 2024-03-31 | $160.03M | $73.91M | $107.44M | $12.36M | $40.22M | $24.60M | 2.17× |
| 2023-12-31 | $170.71M | $72.50M | $125.49M | $2.98M | $42.24M | $21.84M | 2.35× |
| 2023-09-30 | $186.42M | $60.38M | $124.61M | $13.43M | $48.38M | $24.02M | 3.09× |
| 2023-06-30 | $221.28M | $59.37M | $167.69M | $2.46M | $51.13M | $30.74M | 3.73× |
| 2023-03-31 | $228.45M | $63.38M | $164.14M | $10.43M | $53.88M | $38.82M | 3.60× |
| 2022-12-31 | (m) | $65.35M | $187.01M | (m) | $62.73M | $34.09M | (m) |
| 2022-09-30 | (m) | $65.74M | $209.63M | (m) | $50.53M | $35.73M | (m) |
| 2022-06-30 | (m) | $59.34M | $223.62M | (m) | $31.15M | $33.50M | (m) |
| 2022-03-31 | $257.37M | $59.82M | $213.40M | $9.99M | $33.98M | $34.08M | 4.30× |
| 2021-12-31 | $269.96M | $61.51M | $235.52M | $9.99M | $24.45M | $31.87M | 4.39× |
| 2021-09-30 | $278.03M | $59.93M | $241.58M | $3.55M | $32.91M | $31.79M | 4.64× |
| 2021-06-30 | $286.90M | $61.84M | $238.85M | $11.11M | $36.95M | $27.23M | 4.64× |
| 2021-03-31 | $271.57M | $55.47M | $220.01M | $13.14M | $38.42M | $26.39M | 4.90× |
| 2020-12-31 | $260.94M | $56.71M | $211.96M | $19.26M | $29.72M | $24.82M | 4.60× |
| 2020-09-30 | $252.20M | $51.97M | $213.98M | $6.53M | $31.69M | $29.22M | 4.85× |
| 2020-06-30 | $247.06M | $50.61M | $214.09M | $4.55M | $28.42M | $36.18M | 4.88× |
| 2020-03-31 | (m) | $55.84M | $208.36M | (m) | $40.40M | $37.60M | (m) |
| 2019-12-31 | $243.42M | $50.18M | $198.04M | $11.06M | $34.33M | $35.66M | 4.85× |
| 2019-09-30 | $241.82M | $50.04M | $156.13M | $44.51M | $41.18M | $34.07M | 4.83× |
| 2019-06-30 | $302.87M | $46.36M | $213.95M | $42.20M | $46.72M | $24.48M | 6.53× |
| 2019-03-31 | $280.77M | $43.75M | $190.24M | $49.01M | $41.52M | $28.82M | 6.42× |
| 2018-12-31 | $277.39M | $46.59M | $196.63M | $43.72M | $37.04M | $27.07M | 5.95× |
| 2018-09-30 | $258.11M | $46.13M | $176.28M | $47.57M | $34.25M | $30.62M | 5.60× |
| 2018-06-30 | $245.88M | $47.23M | $166.34M | $42.07M | $37.47M | $27.41M | 5.21× |
| 2018-03-31 | $223.38M | $37.67M | $154.28M | $34.01M | $35.09M | $22.96M | 5.93× |
| 2017-12-31 | $205.39M | $33.89M | $142.95M | $30.99M | $31.44M | $18.84M | 6.06× |
| 2017-09-30 | $197.79M | $35.43M | $129.69M | $33.40M | $34.70M | $16.86M | 5.58× |
| 2017-06-30 | $179.01M | $32.19M | $114.71M | $29.50M | $34.80M | $15.92M | 5.56× |
| 2017-03-31 | $159.17M | $25.29M | $105.11M | $23.14M | $30.93M | $13.96M | 6.29× |
| 2016-12-31 | $144.71M | $22.84M | $92.85M | $21.03M | $30.83M | $14.34M | 6.33× |
| 2016-09-30 | $138.06M | $30.23M | $86.01M | $22.33M | $29.72M | $16.50M | 4.57× |
| 2016-06-30 | (m) | $27.98M | $84.50M | (m) | $27.84M | $12.51M | (m) |
| 2016-03-31 | (m) | $24.04M | $72.40M | (m) | $23.75M | $10.28M | (m) |
| 2015-12-31 | (m) | $22.01M | $66.11M | (m) | $19.87M | $8.65M | (m) |
| 2015-09-30 | (m) | $22.84M | $55.09M | (m) | $20.89M | $9.36M | (m) |
| 2015-06-30 | (m) | $25.09M | $51.82M | (m) | $24.77M | $9.31M | (m) |
| 2015-03-31 | (m) | $22.37M | $61.10M | (m) | $21.81M | $7.79M | (m) |
| 2014-12-31 | (m) | $18.73M | $56.84M | (m) | $19.35M | $7.62M | (m) |
| 2014-09-30 | (m) | $20.48M | $56.16M | (m) | $18.06M | $7.33M | (m) |
| 2014-06-30 | (m) | $26.30M | $69.05M | (m) | $15.64M | $6.10M | (m) |
| 2014-03-31 | (m) | $21.92M | $59.55M | (m) | $18.08M | $4.65M | (m) |
| 2013-12-31 | (m) | $19.28M | $13.52M | (m) | $10.23M | $4.25M | (m) |
| 2013-09-30 | (m) | (m) | $13.52M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $14.17M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | $14.13M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $15.11M | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | $15.11M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $3.91M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |